Renaparin

N/A

Report date: 2025/04/21 20:01:10

Base Information

Drug NameRenaparin
Drug Alias Name瑞那肝素Renaparin
ClassificationBiologics
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIICoagulation factor XProthrombin
Therapy Area/IndicationsDelayed Graft Function
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVedanta Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCorline Biomedical Ab
Active IndicationsN/A
Inactive IndicationsDelayed Graft Function

Other Information

ATC CodeN/A
Related LinksN/A